Amicus Therapeutics, Inc. (FOLD)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 09:51AM EDT. Market open.
| Previous close | 10.43 |
| Open | 10.51 |
| Bid | 10.39 x 300 |
| Ask | 10.44 x 100 |
| Day's range | 10.39 - 10.61 |
| 52-week range | 9.70 - 14.57 |
| Volume | |
| Avg. volume | 3,057,075 |
| Market cap | 3.089B |
| Beta (5Y monthly) | 0.76 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Will Amicus Therapeutics (FOLD) Report Negative Q1 Earnings? What You Should Know
Amicus Therapeutics (FOLD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
When Will Amicus Therapeutics, Inc. (NASDAQ:FOLD) Become Profitable?
Amicus Therapeutics, Inc. ( NASDAQ:FOLD ) is possibly approaching a major achievement in its business, so we would like...
- Zacks
Why Is Amicus Therapeutics (FOLD) Down 8.1% Since Last Earnings Report?
Amicus Therapeutics (FOLD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2024 Yahoo. All rights reserved.